Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 14, Art. 83 (pp. 1051-1056)    |    2013       

»

Clinical and laboratory rates related to liver lesion in patients with malignant lymphomas

Kvasova E.V., Novitskiy А.V., Gordienko A.V., Pyatibrat E.D.
Military Medical Academy. SM Kirov, St. Petersburg

Brief summary

A number of clinical and laboratory criteria of liver lesion in patients with malignant lymphomas have been verified in a given research. It was revealed that liver cancer lesion within malignant lymphomas is characterized by emerged functional disorders. A significant increase of white blood cells and lymphocytes in the patients with indolent liver lesions was detected. The increase of alkaline phosphatase and alanine transaminase are considered an important prognostic feature of liver lesion at malignant lymphomas.


Key words

hemoblastosis, functional liver disorders, malignant lymphomas, biochemical markers of cancer activity.

Reference list

1. Davidov, M. I. Statistika zlokachestvennih novoobrazovanii v Rossii i stranah SNG v 2007 g. / M.I. Davidov, E.M. Aksel // Vestnik RONC. – 2009. – T. 20, № 3. – 15 s.


2. Dacenko, P.V. Faktori riska gematologicheskoi toksichnosti i mnogoparametricheskii analiz laboratornih pokazatelei krovi pri limfome Hodjkina: model gematologicheskoi toksichnosti / P.V. Dacenko [i dr.] // Vopr. onkologii. – 2010. – T. 56, № 5. – S. 571–575.


3. Avery, A. Molecular diagnostics of hematologic malignancies / A. Avery // Top, co. anim. med. – 2009. – Vol. 24, № 3. – P. 144–150.


4. Bindea, G. Natural immunity to cancer in humans / G. Bindea // Curr. opin. immunol. – 2010. – Vol. 22, № 2. – P. 215–222.


5. Masood A. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment / A. Masood, S. Sallah // Leuk. Res. – 2005. – № 29 – P. 493-501.


6. Nathwani R.A. Drug hepatotoxicity / R.A. Nathwani, N. Kaplowitz // Clin. Liver Dis. – 2006. – № 10 – P. 207-217.